Could a common sleep pill boost PTSD treatment in veterans?

NCT ID NCT06788522

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether suvorexant, a medication already approved for insomnia, can help Veterans with PTSD and sleep problems better unlearn fear responses. About 40 Veterans will take either suvorexant or a placebo for 7 nights while researchers measure their skin responses to fear cues. The goal is to see if blocking orexin, a brain chemical that promotes wakefulness, can enhance fear extinction—a key process in PTSD recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Suvorexant
What this could lead to
If it works, this could point toward a new way to enhance PTSD treatment by improving how the brain unlearns fear responses.
What could go wrong
This is a very small early study (40 participants) focused on lab-based fear measures, not real-world PTSD symptoms. Results may not translate to clinical improvement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INSOMNIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ralph H. Johnson VA Medical Center, Charleston, SC

    Charleston, South Carolina, 29401-5703, United States

  • San Francisco VA Medical Center, San Francisco, CA

    San Francisco, California, 94121-1563, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.